Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Anne Gershon"'
Autor:
Christine Miller, Emma Taylor-Salmon, Leonard Emuren, Marie Landry, Anne Gershon, George Miller
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background Herpes zoster (HZ) is the clinical syndrome associated with reactivation of latent varicella-zoster virus (VZV). Several factors have been implicated to promote VZV reactivation; these include immunosuppression, older age, mechani
Externí odkaz:
https://doaj.org/article/167647e9189341fdb4348bb69ffa3bf3
Autor:
Mirella Mourad, Michael Gershon, Satish K. Mehta, Brian E. Crucian, Nicole Hubbard, Jing Zhang, Anne Gershon
Publikováno v:
Viruses, Vol 14, Iss 7, p 1438 (2022)
We encountered two cases of varicella occurring in newborn infants. Because the time between birth and the onset of the illness was much shorter than the varicella incubation period, the cases suggested that the infection was maternally acquired, des
Externí odkaz:
https://doaj.org/article/999d8056130b4e6ab3d84bb66ba99126
Autor:
Howard Andrews, D P Devanand, William C Kreisl, Qolamreza Razlighi, Anne Gershon, Yaakov Stern, Akiva Mintz, Thomas Wisniewski, Edward Acosta, Julianna Pollina, Mariasofia Katsikoumbas, Karen L Bell, Gregory H Pelton, Deborah Deliyannides, K M Prasad
Publikováno v:
BMJ Open, Vol 10, Iss 2 (2020)
IntroductionAfter infection, herpes simplex virus-1 (HSV1) becomes latent in the trigeminal ganglion and can enter the brain via retrograde axonal transport. Recurrent reactivation of HSV1 may lead to neurodegeneration and Alzheimer’s disease (AD)
Externí odkaz:
https://doaj.org/article/203cfb36c06d4121a7b06baf3c06ea77
Autor:
Peter Wutzler, Paolo Bonanni, Margaret Burgess, Anne Gershon, Marco Aurélio Sáfadi, Giacomo Casabona
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 8, Pp 833-843 (2017)
Introduction: Varicella, although a frequently benign childhood disease, nevertheless represents a considerable health burden. WHO recommends including varicella vaccines in universal routine vaccination programs, and maintaining coverage >80%. Many
Externí odkaz:
https://doaj.org/article/8b9083b8b13149d69482f65bfcc2ef6b
Autor:
Ravi Mahalingam, Anne Gershon, Michael Gershon, Jeffrey I. Cohen, Ann Arvin, Leigh Zerboni, Hua Zhu, Wayne Gray, Ilhem Messaoudi, Vicki Traina-Dorge
Publikováno v:
Viruses, Vol 11, Iss 6, p 502 (2019)
Varicella-zoster virus (VZV), an exclusively human herpesvirus, causes chickenpox and establishes a latent infection in ganglia, reactivating decades later to produce zoster and associated neurological complications. An understanding of VZV neurotrop
Externí odkaz:
https://doaj.org/article/b9353f687a1448c59a626239f20ca2b1
Publikováno v:
Journal of the Pediatric Infectious Diseases Society.
Autor:
Anne Gershon
Publikováno v:
VacciTUTOR.
A live attenuated vaccine against varicella (later also used to prevent zoster) was developed in 1974 by Takahashi and colleagues. Varicella vaccine was licensed for universal immunization of healthy children in the United States in 1995. It is also
Autor:
Rishi D. Naik, Anne Gershon, Tina Higginbotham, Jason Chen, Elizabeth Yvonne Flores, Michael Holzman, Dhyanesh A. Patel, Michael D. Gershon, Michael F. Vaezi
Publikováno v:
Gastroenterology. 162:S-326
Background: Two-dose varicella vaccination is recommended for optimal control of varicella in populations with high (>90%) 1-dose coverage. Optimal timing of the second dose may depend on whether breakthrough varicella results from primary vaccine fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0d8fe83e18869dd8653eb5b259d3a53d
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3157931
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3157931